Latest News

Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline

Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.

PHILADELPHIA, PA – (BUSINESS WIRE) – January 25, 2024 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that its latest in silico solution offering known as Advance™ , is providing clients with a technology-enabled approach for assessing carcinogenicity based on the ICH S1B Weight of Evidence (WoE) Addendum.

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

November 27, 2023 - Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

Instem Announces New Software Solution to Support Updated Nitrosamines Guidance

September 28, 2023 - New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)

Instem Announces Transfer of ToxHub Platform and launch of Centrus®

May 15, 2023 - New powerful technology and data sharing suite provides a range of translational science solutions

Instem Unveils New Additions to its Leading Computational Toxicology Software Suite

November 2, 2022 - New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

View all news










Proud to be Presenting at the FDA 2024 Generic Drug Science and Research Initiatives Public Workshop

May 20 - 21, 2024

FDA, White Oak Campus, Silver Spring, MD

Visit Conference Site

'New research in computational toxicology modeling approaches to supplement and expand upon the carcinogenic potency categorization approach to assist generic product development'
Kevin Cross, PhD, VP Regulatory Science, Instem

Solution Areas: In Silico Solutions

Proud to be Presenting at Extractables & Leachables USA

May 21 - 22, 2024

Bethesda, MD

Visit Conference Site

Solution Areas: In Silico Solutions

View all events